CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats

Pancreas

Volumn 16, Issue 2, 1998, Pages 169-175

  Nakano, Shigekazu ^a   Kihara, Yasuyuki ^a   Otsuki, Makoto ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Acute pancreatitis; Cholecystokinin; Exocrine pancreas; Loxiglumide; Pancreatic regeneration

Indexed keywords

AMYLASE; CERULETIDE; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DNA; LOXIGLUMIDE; PANCREAS ENZYME; TRIACYLGLYCEROL LIPASE; TRYPSIN; TRYPSINOGEN;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA CONTENT; DOSE RESPONSE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031882244     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199803000-00011     Document Type: Article

References (36)

1. Lampel M, Kern HF. Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue. Virchows Arch [A] 1977;373:97-117.
2. Niederau C, Liddle RA, Ferrell LD, Grendell JH. Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis. J Clin Invest 1986;78:1056-63.
3. Evander A, Ihse I, Lundquist I. Influence of hormonal stimulation by caerulein on acute experimental pancreatitis in the rat. Eur Surg Res 1981;13:257-68.
4. Evander A, Lundquist I, Ihse I. Influence of gastrointestinal hormones on the course of acute experimental pancreatitis. Hepatogastroenterology 1982;29:161-6.
5. Gomez G, Townsend CM Jr, Green DW, et al. Protective action of luminal bile salts in necrotizing acute pancreatitis in mice. J Clin Invest 1990;86:323-31.
6. Murayama KM, Drew JB, Yokoo H, Joehl RJ. Bile exclusion from the gut exacerbates acute pancreatitis caused by pancreatic duct obstruction in rats. Pancreas 1991;6:175-81.
7. Morisset J, Guan D, Jurkowska G, Rivard N, Green GM. Endogenous cholecystokinin, the major factor responsible for dietary protein-induced pancreatic growth. Pancreas 1992;7:522-9.
8. Otsuki M, Ohki A, Okabayashi Y, Suehiro I, Baba S. Effect of synthetic protease inhibitor camostate on pancreatic exocrine function in rats. Pancreas 1987;2:164-9.
9. Otsuki M, Williams JA. Amylase secretion by isolated pancreatic acini after chronic cholecystokinin treatment in vivo. Am J Physiol 1983;244:G683-8.
10. Majumdar APN, Vesenka GD, Dubick MA. Acceleration of pancreatic regeneration by cholecystokinin in rats. Pancreas 1987;2: 199-204.
11. Jurkowska G, Grondin G, Morisset J. Involvement of endogenous cholecystokinin in pancreatic regeneration after cerulein-induced acute pancreatitis. Pancreas 1992;7:295-304.
12. Jurkowska G, Grondin G, Masse S, Morisset J. Soybean trypsin inhibition and cerulein accelerate recovery of cerulein-induced pancreatitis in rats. Gastroenterology 1992;102:550-62.
13. Niederau C, Ferrell LD, Grendell JH. Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin. Gastroenterology 1985;88:1192-204.
14. Wisner JR Jr, Renner IG. Asperlicin, a nonpeptidal cholecystokinin receptor antagonist, attenuates sodium taurocholate-induced acute pancreatitis in rats. Pancreas 1988;3:174-9.
15. Modlin IM, Bilchik AJ, Zucker KA, Adrian TE, Sussman J. Graham SM. Cholecystokinin augmentation of "surgical" pancreatitis. Benefits of receptor blockade. Arch Surg 1989;124:574-8.
16. Tani S, Okabayashi Y, Nakamura T, Fujii M, Itoh H, Otsuki M. Effect of a new cholecystokinin receptor antagonist loxiglumide on acute pancreatitis in two experimental animal models. Pancreas 1990;5:284-90.
17. Tani S, Itoh H, Koide M, Okabayashi Y, Otsuki M. Involvement of endogenous cholecystokinin in the development of acute pancreatitis induced by closed duodenal loop. Pancreas 1993;8:109-15.
18. Gasslander T, Axelson J, Håkanson R, Ihse I, Lilja I, Rehfeld JF. Cholecystokinin is responsible for growth of the pancreas after pancreaticobiliary diversion in rats. Scand J Gastroenterol 1990; 25:1060-5.
19. Nylander AG, Chen D, Ihse I, Rehfeld JF, Håkanson R, Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide. Scand J Gastroenterol 1992;21:743-7.
20. Nakano S, Tachibana I, Otsuki M. Effect of cholecystokinin receptor antagonist loxiglumide on rat exocrine pancreas. Pancreas 1994;9:425-33.
21. Nakano S, Tachibana I, Otsuki M. Effect of the cholecystokinin receptor antagonist loxiglumide on pancreatic exocrine function in rats after acute pancreatitis. Pancreas 1995;10:287-94.
22. Watanabe N, Otsuki M. Duration and potency of anticholecystokinin action of subcutaneous and oral loxiglumide on cerulein-stimulated pancreatic exocrine secretion. Int J Pancreatol 1993; 13:129-37.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951;193:265-75.
24. Labarca C, Paigen K. A simple, rapid and sensitive DNA assay procedure. Anal Biochem 1980;102:344-52.
25. Ceska M, Birath K, Brown B. A new and rapid method for the clinical determination of α-amylase activities in human serum and urine. Clin Chim Acta 1969;26:437-44.
26. Whitaker JF. A rapid and specific method for the determination of pancreatic lipase in serum and urine. Clin Chim Acta 1973;44: 133-8.
27. Erlanger BF, Kokowaky N, Cohen W. The preparation and properties of two new chromogenic substrates of trypsin. Arch Biochem Biophys 1961;95:271-8.
28. Bilchik AJ, Zucker KA, Adrian TE, Modilin IM. Amelioration of cholinergic-induced pancreatitis with a selective cholecystokinin receptor antagonist. Arch Surg 1990;125:1546-9.
29. Ohsio G, Saluja A, Steer ML. Effects of short-term pancreatic duct obstruction in rats. Gastroenterology 1991;100:196-202.
30. Czako L, Yamamoto Y, Otsuki M. Exocrine pancreatic function in rats after acute pancreatitis. Pancreas 1997;15:83-90.
31. Tachibana I, Shirohara H, Czako L, et al. Role of endogenous cholecystokinin and cholecystokinin-A receptors in the development of acute pancreatitis in rats. Pancreas 1997;14:113-21.
32. Yazu T, Kimura T, Sumii T, Nawata H. Alterations of cholecystokinin receptor binding after caerulein-induced pancreatitis in rats. Digestion 1991;50:142-8.
33. Rivard N, Rydzewska G, Lods J-S, Martinez J, Morisset J. Pancreas growth, tyrosine kinase, PtdIns 3-kinase, and PLD involve high-affinity CCK-receptor occupation. Am J Physiol 1994;266: G62-70.
34. Saluja AK, Saluja M, Printz H, Zavertnik A, Sengupta A, Steer ML. Experimental pancreatitis is mediated by low-affinity cholecystokinin receptors that inhibit digestive enzyme secretion. Proc Natl Acad Sci USA 1989;86:8968-71.
35. Leung YK, Lee PC, Lebenthal E. Maturation of cholecystokinin receptors in pancreatic acini of rats. Am J Physiol 1986;250: G594-7.
36. McQuaid K, Williams JA, Grendel J. CCK-receptor binding affinity changes in diet-induced acute pancreatitis. Dig Dis Sci 1987; 32:1176.